Ly6G+ bone marrow neutrophils from WT, PILR-α-/- or PILRβ1-/- mice were analyzed for indicated antigens by FACS. Representative histograms of at least three independent experiments are shown in (A) …
Source data for Figure 1B and D.
Source data for Figure 1E.
(A) Ly6G+ WT and PILR-α-/- bone marrow cells were stained with a primary antibody recognizing both PILR-α and PILR-β in the absence (black) or presence of 2.5-fold (red) or 5-fold (orange) excess of …
Source data for Figure 1—figure supplement 1B-C.
WT (black), PILR-α-/- (red) and PILR-b1-/- (blue) CD45+ leukocytes from spleen (A), bone marrow (B) or peripheral blood (C) were stained by antibodies against the indicated antigens and analyzed by …
Source data for Figure 1—figure supplement 2A.
Source data for Figure 1—figure supplement 2B (F4/80+).
Source data for Figure 1—figure supplement 2B (Ly6G+).
Source data for Figure 1—figure supplement 2C.
WT, PILR-α-/- and PILR-β1-/- mice were stimulated with intrascrotal TNF-α for 2 hr. Cremaster muscles were exposed and examined for neutrophil extravasation by intravital microscopy (IVM) for (A) …
Source data for Figure 2A, C and D.
Source data for Figure 2B.
Source data for Figure 2A-D (Table 1).
Flow chamber surfaces were coated with P-selectin-Fc, ICAM-1-Fc and CXCL-1, and co-coated with either CD99-Fc or human IgG1 control (hIgG). PILR-α-/- (A) or PILR-β1-/- (B) PMN were mixed with …
Source data for Figure 3A.
Source data for Figure 3B.
Source data for Figure 3C-E.
Source data for Figure 3F.
Source data for Figure 3G.
Source data for Figure 3H.
(A) PMN were pre-treated with non-crosslinking rabbit IgG or crosslinking polyclonal anti-PILRs for 15 min, and then stimulated with 100 ng/ml CXCL-1 for 0 s (unstimulated), 30 s, 60 s and 75 s, …
Source data for Figure 3—figure supplement 1A.
Source data for Figure 3—figure supplement 1B (PILRa-/-).
Source data for Source data for Figure 3—figure supplement 1B (PILRb1-/-).
WT or CD99-/- mice received bone marrow transplantation from WT (A–F) or PILR-α-/- (A–C) or PILR-β1-/- (D–F). IVM measurement of (A, D) rolling flux fraction, (B, E) adhesion and (C, F) …
Source data for Figure 4A–C.
Source data for Figure 4A–C (Table 2).
Source data for Figure 4D–F.
Source data for Figure 4D–F (Table 3).
(A) CHO cells overexpressing CD99 (CHO-CD99) were constructed and analyzed for surface expression of CD99. Solid tracks, anti-CD99; dotted tracks, secondary antibody only. (B) 1:1 Cell mixtures of …
Source data for Figure 5B.
Source data for Figure 5C-D.
Source data for Figure 5E-F.
Source data for Figure 5G.
Parental CHO cells (CHO-WT) or CHO cells expressing full-length CD99 (CHO-CD99FL) were passed over a surface coated with PILR-α-Fc (blue) or PILR-β-Fc (red), or over an uncoated control surface at a …
Source data for Figure 5—figure supplement 1.
(A) CD99-Fc was treated with 0 or 0.3 U/ml sialidase at 37°C for 1 hr and analyzed by Western blot. (B) CHO-CD99 was similarly treated with sialidase. Lysate was prepared and analyzed by Western blot.
Source data for Figure 5—figure supplement 2A-B.
(A) PMN from WT or PILR-β1-/- mice were allowed to adhere onto TNF-α inflamed and CXCL-1 pretreated MDMVEC under stasis. Adherent cells were counted. n = 17 fields per genotype from two experiments. …
Source data for Figure 6A.
Source data for Figure 6B.
Source data for Figure 6C.
Source data for Figure 6D.
(A) Correlation between adhesion and transmigration of WT, PILR-α-/- and PILR-β1-/- PMNs in static transendothelial cell migration (TEM) assays through MDMVEC. n = 96 (WT), 54 (PILR-α-/-) and 41 …
Source data for Figure 7A.
Source data for Figure 7B.
Source data for Figure 7C-D.
(A) WT or PILR-α-/- PMNs were allowed to adhere onto TNF-α stimulated MDMVEC and adherent cells were counted. n = 16 fields from two experiments. (B) WT or PILR-α-/- PMNs were allowed to adhere on …
Source data for Figure 7—figure supplement 1A.
Source data for Figure 7—figure supplement 1B.
Transmigration of WT and PILR-α- /- PMNs towards 40 ng/ml CXCL-1 through polycarbonate transwell filters (3 µm pore size) coated with 2 µg/ml ICAM-1-Fc for 1 hr at 37°C. n = 6 transwells. Groups …
Source data for Figure 7—figure supplement 2.
CHO- WT (black) or overexpressing PILR-α (CHO-PILR-α, blue) were treated with 0 or 0.3 U/ml sialidase at 37°C for 30 min. Cells were washed and probed for CD99-Fc binding. CD99-Fc binding on cell …
An antagonistic pair of receptors, PILR-β1 and PILR-α, supports neutrophil arrest and seamless transition to crawling via modulating β2 integrin activity at different steps during extravasation.
(P value is 0.0658 (2-tailed t-test)).
Genotypes, number of mice, number of venules, venule diameters, leukocyte counts, blood velocities and Newtonian wall shear stresses are shown as mean ± SEM.
Genotype | Mice | Venules | Diameter (μm) | Leukocyte counts (106 cells/ml) | Mean blood velocity (mm/s) | Newtonian wall shear rate (s−1) |
---|---|---|---|---|---|---|
WT | 8 | 40 | 28.7 ± 0.7 | 4.34 ± 0.62 | 1.22 ± 0.02 | 350 ± 9 |
PILRα-/- | 7 | 37 | 29.4 ± 0.8 | 5.19 ± 0.46 | 1.23 ± 0.02 | 343 ± 9 |
PILRβ1-/- | 7 | 35 | 28.2 ± 0.8 | 3.95 ± 0.45 | 1.23 ± 0.02 | 357 ± 10 |
Genotypes of donors and recipients, number of mice, number of venules, venule diameters, leukocyte counts, blood velocities and Newtonian wall shear stresses are shown as mean ± SEM.
Donor genotype (neutrophil) | Recipient genotype (endothelium) | Mice | Venules | Diameter (μm) | Leukocyte counts (106 cells/ml) | Mean blood velocity (mm/s) | Newtonian wall shear rate (s−1) |
---|---|---|---|---|---|---|---|
WT | WT | 5 | 39 | 25.4 ± 0.6 | 3.27 ± 0.19 | 1.21 ± 0.00 | 388 ± 8 |
WT | CD99-/- | 5 | 38 | 24.2 ± 0.5 | 3.52 ± 0.07 | 1.20 ± 0.01 | 404 ± 8 |
PILRα-/- | WT | 5 | 39 | 24.5 ± 0.6 | 2.87 ± 0.11 | 1.20 ± 0.01 | 403 ± 9 |
PILRα-/- | CD99-/- | 4 | 34 | 23.8 ± 0.6 | 3.47 ± 0.12 | 1.21 ± 0.01 | 413 ± 10 |
Genotypes of donors and recipients, number of mice, number of venules, venule diameters, leukocyte counts, blood velocities and Newtonian wall shear stresses are shown as mean ± SEM.
Donor genotype (neutrophil) | Recipient genotype (endothelium) | Mice | Venules | Diameter (μm) | Leukocyte counts (106 cells/ml) | Mean blood velocity (mm/s) | Newtonian wall shear rate (s−1) |
---|---|---|---|---|---|---|---|
WT | WT | 4 | 23 | 23.3 ± 0.7 | 3.13 ± 0.30 | 1.24 ± 0.01 | 431 ± 10 |
WT | CD99-/- | 5 | 27 | 23.4 ± 0.8 | 5.46 ± 0.38 | 1.24 ± 0.01 | 434 ± 12 |
PILRβ1-/- | WT | 5 | 29 | 24.0 ± 0.7 | 4.56 ± 0.88 | 1.23 ± 0.01 | 416 ± 10 |
PILRβ1-/- | CD99-/- | 5 | 36 | 22.6 ± 0.5 | 5.58 ± 0.37 | 1.25 ± 0.01 | 443 ± 9 |
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Genetic reagent (M. musculus) | CD99-/- | PMID: 28223280 | ||
Genetic reagent (M. musculus) | PILR-α-/- | This paper | ||
Genetic reagent (M. musculus) | PILR-β1-/- | This paper | ||
Cell line (C. griseus) | CHO-CD99 | PMID: 15280198 | ||
Antibody | Rabbit anti-PILR-α C-terminus (VD67, polyclonal) | This paper | FC: 5 μg/ml | |
Antibody | Rabbit anti-PILRs (VD65, crossreactive, polyclonal) | This paper | FC: 2 μg/ml Functional assay: 20 μg/ml | |
Antibody | Rat anti-F4/80-FITC (BM8) | Biolegend | Cat# 123107 | FC: 1:100 |
Antibody | Rat anti-LFA-1-PE (H155-78) | Biolegend | Cat# 141005 | FC: 1:100 |
Antibody | Rat anti-Ly6G-(APC or FITC) (1A8) | Biolegend | Cat# 127613 Cat# 127605 | FC: 1:250 |
Antibody | Rat anti-CD11b-PE (M1/70) | Biolegend | Cat# 101207 | FC: 1:100 |
Antibody | Armenian Hamster anti- CD11c-PE (N418) | Biolegend | Cat# 117307 | FC: 1:100 |
Antibody | Rat anti-CD45-APC (30F11) | Biolegend | Cat# 103111 | FC: 1:100 |
Antibody | Rat anti-CD182-FITC (SA045E1) | Biolegend | Cat# 149607 | FC: 1:100 |
Antibody | Mouse anti-NK1.1-PE (PK136) | Biolegend | Cat# 108707 | FC: 1:100 |
Antibody | Rat anti-B220-PE (RA3-6B2) | BD Biosciences | Cat# 93992 | FC: 1:100 |
Antibody | Rat anti-CD4-PE (RM4-5) | BD Biosciences | Cat# 26589 | FC: 1:100 |
Antibody | Rat anti-CD162-PE (2PH1) | BD Pharmingen | Cat# 555306 | FC: 1:100 |
Antibody | Rat anti-CD8-FITC (53–6.7) | eBioscience | Cat# 11-0081-85 | FC: 1:100 |
Antibody | Rabbit anti-Syk (polyclonal) | Thermo Fisher | Cat# PA5-27262 | IP: 3 μg/ 5×106 PMN WB: 1:1000 |
Antibody | Mouse anti-phosphotyrosine (4G10) | Merck Millipore | Cat# 05–321 | WB: 1 μg/ml |
Peptide, recombinant protein | CD99-Fc | PMID: 15280198 | ||
Peptide, recombinant protein | P-sel-Fc | PMID: 28223280 | ||
Peptide, recombinant protein | ICAM-1-Fc | PMID: 28223280 | ||
Peptide, recombinant protein | TNF-α | PeproTech | Cat# 315-01A | |
Commercial assay or kit | GeneArt Precision gRNA Synthesis Kit | Thermo Fisher | A29377 | |
Software, algorithm | FlowJo v10 | FlowJo, LLC | ||
Software, algorithm | CytExpert | Beckman Coulter | v2.3.0.84 FACS data acquisition | |
Software, algorithm | Zeiss ZEN (blue edition) | Zeiss | Image/video acquisition | |
Software, algorithm | Fiji Image J | PMID: 27713081 | Plugin: Trackmate |